Core Viewpoint - Dongpeng Beverage has launched a new sugar-free version of its flagship product, Dongpeng Special Drink, indicating a strategic shift towards healthier beverage options in response to consumer demand and market trends [1][9]. Product Launch - The new sugar-free Dongpeng Special Drink is available in a 500ml bottle priced at 4.89 yuan, representing a move towards "consumption upgrade" from the traditional 4 yuan price point [1][3]. - This product is part of a broader strategy that includes previous launches of sugar-free variants, such as the 310ml Dongpeng Zero Sugar Drink and the 555ml sugar-free electrolyte water [3]. Ingredient Innovation - The new sugar-free drink includes L-α-GPC, an ingredient that is claimed to help alleviate brain fatigue, which has been approved as a new food ingredient by the National Health Commission of China [4][5]. - The recommended daily intake of L-α-GPC is ≤600mg, but it is advised that certain populations, such as infants and pregnant women, should avoid it due to insufficient safety data [4]. Market Context - The functional beverage market is experiencing a slowdown, with revenue growth dropping from 38.4% in 2023 to 28.5% in 2024, indicating market saturation [9]. - Dongpeng Beverage's reliance on its flagship product, which accounted for over 80% of its revenue in 2024, poses a risk as competitors like Red Bull and others have already introduced sugar-free options [8][9]. Competitive Landscape - The introduction of the sugar-free variant aligns with a growing consumer preference for low-sugar and sugar-free products, driven by health concerns related to high sugar intake [9]. - Competitors such as Red Bull have re-entered the market with their own sugar-free products, increasing pressure on Dongpeng Beverage to innovate and diversify its product offerings [8][9]. Strategic Implications - The launch of the sugar-free Dongpeng Special Drink is seen as a response to the health-conscious consumer trend and is part of a broader strategy to expand product categories and reduce dependency on a single product line [5][8]. - The company is also looking to leverage its upcoming listing in Hong Kong to enhance its capital base and accelerate its expansion into international markets, particularly in the health beverage segment [9].